Stay updated with breaking news from Pathogen Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health, who have developed the nanotechnology based vaccine, say it has shown strong efficacy in preclinical disease models.
The vaccine candidate developed at the Cleveland Clinic's Global Center for Pathogen Research & Human Health shows promise in preclinical studies.
A new nanoparticle-based vaccine has demonstrated success in ferret models of COVID-19, inducing strong neutralising antibodies.
Metabolon Collaborates with Cleveland Clinic to Enable Novel Discoveries Leveraging Metabolomics to Accelerate Research, Drug Development and Precision Medicine News provided by Share this article MORRISVILLE, N.C., Feb. 18, 2021 /PRNewswire/ -- Metabolon, Inc. has entered into to a multi-year collaborative agreement with Cleveland Clinic to provide Metabolon's Precision Metabolomics™ services in support of drug development and related research efforts. Metabolon will leverage its proprietary platform to analyze a range of biologic samples to help discover metabolomic biomarkers that...
New Cleveland Clinic biorepository building aims to capitalize on Ohio-funded ‘innovation district,’ developer says Eric Heisig, cleveland.com © David Petkiewicz, cleveland.com/David Petkiewicz, cleveland.com/cleveland.com/TNS Brooks Life Sciences is building a specimen repository on Carnegie and E. 100th Street, right across from the main Cleveland Clinic campus. David Petkiewicz, cleveland.com CLEVELAND, Ohio — Developers and a company behind a new building on the Cleveland Clinic’s campus designed to be a centralized biorepository want the project to correspond w...